Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 97 Records) |
| Query Trace: Glioma and MGMT[original query] |
|---|
| An insertion variant of MGMT disrupts a STAT1 binding site and confers susceptibility to glioma. Cancer cell international 2021 Sep 21 (1): 506. Huang Liming, Xu Wenshen, Yan Danfang, Shi Xi, You Xin, Xu Jiaqi, You Pingping, Ke Yuanyuan, Dai Li |
| High-dose radiotherapy in newly diagnosed low-grade gliomas with nonmethylated O(6)-methylguanine-DNA methyltransferase. Radiation oncology (London, England) 2021 Aug 16 (1): 157. Liu Yanwei, Li Yanong, Wang Peng, Chen Li, Feng Jin, Qiu Xiaogua |
| High prevalence of developmental venous anomaly in adult patients with midline thalamic diffuse gliomas. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2021 4 87 59-65. Zhou Xingwang, Niu Xiaodong, Mao Qing, Liu Yanh |
| Dynamic contrast-enhanced MRI may be helpful to predict response and prognosis after bevacizumab treatment in patients with recurrent high-grade glioma: comparison with diffusion tensor and dynamic susceptibility contrast imaging. Neuroradiology 2021 3 63 (11): 1811-1822. Park Yae Won, Ahn Sung Soo, Moon Ju Hyung, Kim Eui Hyun, Kang Seok-Gu, Chang Jong Hee, Kim Se Hoon, Lee Seung-K |
| A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma. Frontiers in oncology 2021 11 771512. Feng Qinglin, Qian Cheng, Fan Shibi |
| ADD3 Deletion in Glioblastoma Predicts Disease Status and Survival. Frontiers in oncology 2021 12 11 717793. Kiang Karrie Mei-Yee, Sun Stella, Leung Gilberto Ka-K |
| Glioma Imaging by O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Diffusion-Weighted MRI and Correlation With Molecular Phenotypes, Validated by PET/MR-Guided Biopsies. Frontiers in oncology 2021 12 11 743655. Cheng Ye, Song Shuangshuang, Wei Yukui, Xu Geng, An Yang, Ma Jie, Yang Hongwei, Qi Zhigang, Xiao Xinru, Bai Jie, Xu Lixin, Hu Zeliang, Sun Tingting, Wang Leiming, Lu Jie, Lin Qingta |
| Clinical and Prognostic Implications of 1p/19q, IDH, BRAF, MGMT Promoter, and TERT Promoter Alterations, and Expression of Ki-67 and p53 in Human Gliomas. Cancer management and research 2021 12 13 8755-8765. Yang Zixi, Ling Feng, Ruan Sibei, Hu Jiajia, Tang Mingxi, Sun Xingwang, Long Wen |
| Discrimination between 34 of 36 Possible Combinations of Three C>T SNP Genotypes in the MGMT Promoter by High Resolution Melting Analysis Coupled with Pyrosequencing Using A Single Primer Set. International journal of molecular sciences 2021 Nov 22 (22): . Zappe Katja, Pirker Christine, Miedl Heidi, Schreiber Martin, Heffeter Petra, Pfeiler Georg, Hacker Stefan, Haslik Werner, Spiegl-Kreinecker Sabine, Cichna-Markl Marg |
| TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy. Cancers 2021 11 13 (21): . Noor Humaira, Briggs Nancy E, McDonald Kerrie L, Holst Jeff, Vittorio Oraz |
| Integrative analysis of CBR1 as a prognostic factor associated with IDH-mutant glioblastoma in the Chinese population. American journal of translational research 2022 9 14 (8): 5394-5408. Ji Pengxiang, Shan Xueshi, Wang Jian, Zhang Ping, Cai Zh |
| Serum microRNA-4297 is a sex-specific predictive biomarker of glioma grade and prognosis. Frontiers in neurology 2022 8 13 888221. Xu Wenshen, Huang Liming, Xie Bingsen, Yang B |
| Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients. Neuro-oncology 2022 Jul . Reyes-González Jesús, Barajas-Olmos Francisco, García-Ortiz Humberto, Magraner-Pardo Lorena, Pons Tirso, Moreno Sergio, Aguirre-Cruz Lucinda, Reyes-Abrahantes Andy, Martínez-Hernández Angélica, Contreras-Cubas Cecilia, Barrios-Payan Jorge, Ruiz-Garcia Henry, Hernandez-Pando Rogelio, Quiñones-Hinojosa Alfredo, Orozco Lorena, Abrahantes-Pérez María Del Carm |
| Clinical, histopathological, and molecular features of IDH-wildtype indolent diffuse glioma: comparison with typical glioblastoma. Journal of neuro-oncology 2022 7 159 (2): 397-408. Suzuki Hayato, Ono Takahiro, Koyota Souichi, Takahashi Masataka, Sugai Tamotsu, Nanjo Hiroshi, Shimizu Hiroa |
| HLA-G 14bp Ins/Del Polymorphism, Plasma Level of Soluble HLA-G, and Association with IL-6/IL-10 Ratio and Survival of Glioma Patients. Diagnostics (Basel, Switzerland) 2022 5 12 (5): . Bucova Maria, Kluckova Kristina, Kozak Jan, Rychly Boris, Suchankova Magda, Svajdler Marian, Matejcik Viktor, Steno Juraj, Zsemlye Eszter, Durmanova Vladimi |
| Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (11): 2440-2448. Draaisma Kaspar, Tesileanu C Mircea S, de Heer Iris, Klein Martin, Smits Marion, Reijneveld Jaap C, Clement Paul M, de Vos Filip Y F, Wick Antje, Mulholland Paul J, Taphoorn Martin J B, Weller Michael, Chinot Olivier L, Kros Johan M, Verschuere Tina, Coens Corneel, Golfinopoulos Vassilis, Gorlia Thierry, Idbaih Ahmed, Robe Pierre A, van den Bent Martin J, French Pim |
| Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma. Bosnian journal of basic medical sciences 2022 3 22 (5): 728-750. Wang Jie, Ren Jie, Liu Jifeng, Zhang Linyun, Yuan Qihang, Dong B |
| Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review. PloS one 2022 3 17 (3): e0264740. Fitt Beth, Loy Grace, Christopher Edward, Brennan Paul M, Poon Michael Tin Chu |
| High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta neuropathologica 2022 2 143 (3): 403-414. Pratt Drew, Abdullaev Zied, Papanicolau-Sengos Antonios, Ketchum Courtney, Panneer Selvam Pavalan, Chung Hye-Jung, Lee Ina, Raffeld Mark, Gilbert Mark R, Armstrong Terri S, Pytel Peter, Borys Ewa, Klonoski Joshua M, McCord Matthew, Horbinski Craig, Brat Daniel, Perry Arie, Solomon David, Eberhart Charles, Giannini Caterina, Quezado Martha, Aldape Kenne |
| The Significance of MGMT Promoter Methylation Status in Diffuse Glioma. International journal of molecular sciences 2022 11 23 (21): . Jovanovi? Nikola, Lazarevi? Milica, Cvetkovi? Vladimir J, Nikolov Vesna, Kosti? Peri? Jelena, Ugrin Milena, Pavlovi? Sonja, Mitrovi? Tatja |
| Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study. Journal of neuro-oncology 2022 1 156 (3): 625-634. Moitra Prithwijit, Chatterjee Abhishek, Kota Priti Khatri, Epari Sridhar, Patil Vijay, Dasgupta Archya, Kowtal Pradnya, Sarin Rajiv, Gupta Tejp |
| The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma. Frontiers in immunology 2022 13 998236. Wang Weichen, Lu Zhichao, Wang Maoyu, Liu Zongheng, Wu Bing, Yang Chengkai, Huan He, Gong Peip |
| RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients. Pharmaceuticals (Basel, Switzerland) 2023 5 16 (5): . Ricardo D Gonzalez, George W Small, Adrian J Green, Farida S Akhtari, Tammy M Havener, Julia C F Quintanilha, Amber B Cipriani, David M Reif, Howard L McLeod, Alison A Motsinger-Reif, Tim Wiltshi |
| Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort. Acta neuropathologica communications 2024 7 12 (1): 120. Nobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, Hiroshi Kawaji, Ema Yoshioka, Yoshinori Kodama, Kosuke Nakajo, Takehiro Uda, Kentaro Naito, Noriyuki Kijima, Yoshiko Okita, Naoki Kagawa, Yoshinobu Takahashi, Naoya Hashimoto, Hideyuki Arita, Koji Takano, Daisuke Sakamoto, Tomoko Iida, Yoshiki Arakawa, Takeshi Kawauchi, Yukihiko Sonoda, Yuta Mitobe, Kenichi Ishibashi, Masahide Matsuda, Takamune Achiha, Takahiro Tomita, Masahiro Nonaka, Keijiro Hara, Noriyoshi Takebe, Takashi Tsuzuki, Yoshikazu Nakajima, Shiro Ohue, Nobuyuki Nakajima, Akira Watanabe, Akihiro Inoue, Masao Umegaki, Daisuke Kanematsu, Asako Katsuma, Miho Sumida, Tomoko Shofuda, Masayuki Mano, Manabu Kinoshita, Kanji Mori, Naoyuki Nakao, Yonehiro Kanemu |
| Immune cell infiltration and inflammatory landscape in primary brain tumours. Journal of translational medicine 2024 5 22 (1): 521. Amalia Luce, Marianna Abate, Giosuè Scognamiglio, Marco Montella, Domenico Iervolino, Severo Campione, Annabella Di Mauro, Orlando Sepe, Vincenzo Gigantino, Madhura S Tathode, Gerardo Ferrara, Roberto Monaco, Gianfranco De Dominicis, Gabriella Misso, Vittorio Gentile, Renato Franco, Silvia Zappavigna, Michele Caragl |
| Prognostic signature detects homologous recombination deficient in glioblastoma. Translational cancer research 2024 12 13 (11): 5883-5897. Dongdong Luo, Aiping Luo, Su Hu, Hailin Zhao, Xuefeng Yao, Dan Li, Biao Pe |
| Novel signature of ferroptosis-related long non-coding RNA to predict lower-grade glioma overall survival. Discover oncology 2024 11 15 (1): 723. Shiji Wu, Wenxi Wu, Yaqi Zhong, Xingte Chen, Junxin |
| CDKN2A Homozygous Deletion Is a Stronger Predictor of Outcome than IDH1/2-Mutation in CNS WHO Grade 4 Gliomas. Biomedicines 2024 10 12 (10): . Sang Hyuk Lee, Tae Gyu Kim, Kyeong Hwa Ryu, Seok Hyun Kim, Young Zoon K |
| Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide. medRxiv : the preprint server for health sciences 2024 10 . Geno Guerra, George Wendt, Lucie McCoy, Helen M Hansen, Linda Kachuri, Annette M Molinaro, Terri Rice, Victoria Guan, Lianne Capistrano, Allison Hsieh, Veruna Kalsi, Jaimie Sallee, Jennie W Taylor, Jennifer L Clarke, Eduardo Rodriguez Almaraz, John K Wiencke, Jeanette E Eckel-Passow, Robert B Jenkins, Margaret Wrensch, Stephen S Franc |
| Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas. Frontiers in oncology 2025 1 14 1507335. Xinli Zhang, Jue Lu, Xiaoming Liu, Peng Sun, Qian Qin, Zhengdong Xiang, Lan Cheng, Xiaoxiao Zhang, Xiaotong Guo, Jing Wa |
- Page last reviewed:Feb 1, 2024
- Content source: